Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
NCT00232752
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
4.0 CYPHER Sirolimus-Eluting Coronary Stent
Sponsor
Cordis US Corp.